Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFL24412 vs Ketoprofen Lysine Salt in Chronic Low Back Pain
2024-513940-27-00Phase 2Completed
- Sponsor
- Dompé
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of DFL24412 in chronic low back pain (CLBP) (3 arms), sponsored by Dompé. Started Sep 2024; status: completed.
02
Drugs
DFL24412
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2024-513940-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513940-27-00.